CN101686955A - 用于治疗睡眠相关呼吸障碍的方法和包含去甲基文拉法辛或度洛西汀的组合物 - Google Patents

用于治疗睡眠相关呼吸障碍的方法和包含去甲基文拉法辛或度洛西汀的组合物 Download PDF

Info

Publication number
CN101686955A
CN101686955A CN200880018706A CN200880018706A CN101686955A CN 101686955 A CN101686955 A CN 101686955A CN 200880018706 A CN200880018706 A CN 200880018706A CN 200880018706 A CN200880018706 A CN 200880018706A CN 101686955 A CN101686955 A CN 101686955A
Authority
CN
China
Prior art keywords
odv
sleep
duloxetine
treatment
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880018706A
Other languages
English (en)
Chinese (zh)
Inventor
迪安·A·汉德利
拉里·W·哈代
梅达德·瓦里茨·帕瑟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of CN101686955A publication Critical patent/CN101686955A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN200880018706A 2007-04-09 2008-04-08 用于治疗睡眠相关呼吸障碍的方法和包含去甲基文拉法辛或度洛西汀的组合物 Pending CN101686955A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92246607P 2007-04-09 2007-04-09
US60/922,466 2007-04-09
PCT/US2008/004508 WO2008124128A2 (en) 2007-04-09 2008-04-08 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders

Publications (1)

Publication Number Publication Date
CN101686955A true CN101686955A (zh) 2010-03-31

Family

ID=39831524

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880018706A Pending CN101686955A (zh) 2007-04-09 2008-04-08 用于治疗睡眠相关呼吸障碍的方法和包含去甲基文拉法辛或度洛西汀的组合物

Country Status (15)

Country Link
US (3) US20080293823A1 (enExample)
EP (2) EP2455076A1 (enExample)
JP (1) JP2010523662A (enExample)
KR (1) KR20100015923A (enExample)
CN (1) CN101686955A (enExample)
AR (1) AR065989A1 (enExample)
AU (1) AU2008236624A1 (enExample)
BR (1) BRPI0810159A2 (enExample)
CA (1) CA2683697C (enExample)
IL (1) IL201430A0 (enExample)
MX (1) MX2009010805A (enExample)
NZ (1) NZ580250A (enExample)
RU (1) RU2009141168A (enExample)
TW (1) TW200901956A (enExample)
WO (1) WO2008124128A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011085256A2 (en) * 2010-01-07 2011-07-14 Vivus, Inc. Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
WO2011155797A2 (ko) * 2010-06-10 2011-12-15 동아제약 주식회사 결정형 오-데스메틸벤라팍신의 헤미옥살레이트염, 그의 제조방법 및 그의 약제학적 조성물
JP7422666B2 (ja) 2018-01-30 2024-01-26 アプニメッド，インコーポレイテッド（デラウェア） 睡眠時無呼吸を治療するための方法および組成物
SG11202108225QA (en) * 2019-02-08 2021-08-30 Brigham & Womens Hospital Inc Methods and compositions for treating sleep apnea

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
US5803066A (en) * 1992-05-07 1998-09-08 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US6150396A (en) * 1997-03-07 2000-11-21 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
JP2002501892A (ja) 1998-01-29 2002-01-22 セプラコア インコーポレーテッド 光学的に純粋な（−）−ビュープロピオンの薬学的使用
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
ES2305606T3 (es) * 1999-04-06 2008-11-01 Sepracor Inc. Succinato de o-desmetilvenlafaxina.
WO2000076955A1 (en) * 1999-06-15 2000-12-21 American Home Products Corporation Enantiomers of o-desmethyl venlafaxine
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
WO2005079761A1 (en) * 2004-02-17 2005-09-01 Transoral Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
AU2005319367B2 (en) * 2004-12-20 2012-05-24 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
JP5197361B2 (ja) * 2005-06-06 2013-05-15 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ 睡眠障害を処置するための組成物および方法
WO2007026219A2 (en) * 2005-08-31 2007-03-08 Pfizer Products Inc. Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions
WO2008103461A2 (en) * 2007-02-21 2008-08-28 Sepracor Inc. Solid forms comprising (-) o-desmethylvenlafaxine and uses thereof
WO2009023820A1 (en) * 2007-08-16 2009-02-19 Cypress Biosciences, Inc. Improving the tolerability of a serotonin antagonist and a nsri, a snri or a rima by using them in combination

Also Published As

Publication number Publication date
AR065989A1 (es) 2009-07-15
KR20100015923A (ko) 2010-02-12
RU2009141168A (ru) 2011-05-20
CA2683697C (en) 2016-08-16
CA2683697A1 (en) 2008-10-16
TW200901956A (en) 2009-01-16
MX2009010805A (es) 2009-10-29
US20080293823A1 (en) 2008-11-27
WO2008124128A2 (en) 2008-10-16
BRPI0810159A2 (pt) 2014-12-30
EP2142183A2 (en) 2010-01-13
JP2010523662A (ja) 2010-07-15
WO2008124128A3 (en) 2009-05-07
US20120238616A1 (en) 2012-09-20
AU2008236624A1 (en) 2008-10-16
EP2455076A1 (en) 2012-05-23
IL201430A0 (en) 2010-05-31
US20150196531A1 (en) 2015-07-16
NZ580250A (en) 2012-05-25

Similar Documents

Publication Publication Date Title
AU2009257572B2 (en) Low dose topiramate/phentermine composition and methods of use thereof
US20200188313A1 (en) Low dose topiramate/phentermine composition and methods of use thereof
CA2383785C (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
US20090264522A1 (en) Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
CN1543344A (zh) 治疗尿失禁的芳基(或杂芳基)氮杂茂甲醇衍生物
WO2022221613A1 (en) Combination of a norepinephrine reuptake inhibitor and a cannabinoid for use in treating sleep apnea
CN101686955A (zh) 用于治疗睡眠相关呼吸障碍的方法和包含去甲基文拉法辛或度洛西汀的组合物
JP2008519810A (ja) 顔面紅潮の治療のためのｓミルタザピン
AU2019213277B2 (en) Compositions and methods for treating obstructive sleep apnea
CN117956959A (zh) 用于治疗睡眠呼吸暂停的方法和组合物
CN103169716A (zh) 用于治疗疼痛的复方药物组合
HK1142005A (en) Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders
CN101325950A (zh) 用依他普仑和安非他酮的低剂量组合物治疗中枢神经系统病症的方法
AU2018201464A1 (en) Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1142005

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100331

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1142005

Country of ref document: HK